feed,title,long_url,short_url
Benzinga,Global Blood Therapeutics' Oxbryta Scores European Approval For Sickle Cell Disease,https://benzinga.com/general/biotech/22/02/25660191/global-blood-therapeutics-oxbryta-scores-european-approval-for-sickle-cell-disease,https://bit.ly/3BDYAmt
Benzinga,Why Is Facebook Parent Meta's Stock Trading Lower Today?,https://benzinga.com/government/22/02/25661783/why-is-facebook-parent-metas-stock-trading-lower-today,https://bit.ly/3BtHFmu
